Header Logo

Connection

EVELINE BARBIERI to Sirolimus

Back to Details
This is a "connection" page, showing publications EVELINE BARBIERI has written about Sirolimus.
EVELINE BARBIERI
Connection Strength
0.126
Sirolimus
  1. p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy. Clin Cancer Res. 2017 Nov 01; 23(21):6629-6639.
    View in: PubMed
    Score: 0.126
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.